↓ Skip to main content

Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia

Overview of attention for article published in Future Oncology, January 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy
1 policy source
twitter
4 X users

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
75 Mendeley
citeulike
1 CiteULike